Stay updated on Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.

Latest updates to the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page
- Check7 days agoChange DetectedThe page now displays a new revision tag 'Revision: v3.5.5' replacing the previous 'Revision: v3.5.4', indicating a content/system revision.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 on the page, indicating a routine update to the page's version metadata.SummaryDifference0.0%

- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe Taiwan site entry was updated from Taoyuan District, Taiwan to Taoyuan, Taiwan, keeping the same postal code. This clarifies the exact city-level location for that recruitment site.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3, indicating a minor version update to the page rendering rather than changes to the study content.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision: v3.5.0 appears on the page, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.